DAS# remission

Related by string. * DAS# [002] . DAS# [001] : DAS# CRP . DAS# Fludase ® . Score DAS# . DAS# scores / Remissions . Remission . remissions : endoscopic remission . spontaneous remission . remission Bobbit . induce remission . complete remissions . remission induction . remission CR . partial remissions . Complete Remission . durable remissions . molecular remissions . Clinical Remission * *

Related by context. Frequent words. (Click for all words.) 68 annualized relapse 66 cytogenetic response 66 adalimumab 65 DAS# [002] 65 plus dexamethasone 64 mg QD 64 plus methotrexate 64 RECIST criteria 63 serum concentrations 63 Secondary endpoints include 63 serum phosphorus 63 ADAS cog 63 median PFS 63 ACR# [002] 63 decitabine 62 sustained virologic response 62 estimated glomerular filtration 62 peginterferon alfa 2a 62 statistically significant p = 62 confidence interval #.#-#.# 62 Cmax 62 T2DM 62 glycated hemoglobin 62 PsA 62 mg kg dose 62 virologic response 62 mg BID 61 tocilizumab 61 pg mL 61 virologic failure 61 RECIST 61 noninferiority 61 irbesartan 61 plus prednisone 61 HSCT 61 univariate analysis 61 evaluable patients 61 neoadjuvant chemotherapy 61 mitoxantrone 60 placebo p = 60 active comparator 60 peginterferon alfa 2b 60 HbA 1c 60 DOXIL 60 evaluable 60 XELOX 60 Secondary endpoints 60 Secondary endpoints included 60 EDSS 60 EBRT 60 PANSS 60 μg kg 60 COPAXONE R 60 glomerular filtration rate 59 achieved statistical significance 59 Solid Tumors 59 tipranavir 59 neoadjuvant 59 glatiramer acetate 59 risedronate 59 DMARD 59 COPD exacerbations 59 FOLFIRI 59 sd = 59 Arch Intern Med 59 lacosamide 59 infliximab 59 P = .# 59 etanercept 59 CI -#.# 59 TACE 59 azacitidine 59 mcg dose 59 mycophenolate mofetil 59 univariate 59 nonresponders 59 placebo p 59 thromboembolic events 59 Lenalidomide 59 chemoradiotherapy 58 % CI #.#-#.# [006] 58 CI #.#-#.# [002] 58 enalapril 58 tamsulosin 58 cabazitaxel 58 linezolid 58 nab paclitaxel 58 mcg kg 58 relapsed refractory multiple myeloma 58 Taxotere ® 58 Fludara 58 free survival PFS 58 interferon alfa 58 Navelbine 58 sinus rhythm 58 IPSS 58 patients evaluable 58 metastatic renal cell carcinoma 58 Disease Activity 58 limiting toxicity 58 neoadjuvant therapy

Back to home page